87 related articles for article (PubMed ID: 3527910)
1. [Treatment of irritated stomach with cisapride. A placebo-controlled double-blind study].
Rösch W; Panijel M; Schwarz W; Dilla H; Giesecke HJ; Gabriel H; Kullik R; Leber W; Weitendorff F; Daake H
Fortschr Med; 1986 Jul; 104(27-28):544-6. PubMed ID: 3527910
[No Abstract] [Full Text] [Related]
2. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
Deruyttere M; Lepoutre L; Heylen H; Samain H; Pennoit H
Clin Ther; 1987; 10(1):44-51. PubMed ID: 3329964
[TBL] [Abstract][Full Text] [Related]
3. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
Corinaldesi R; Stanghellini V; Raiti C; Rea E; Salgemini R; Barbara L
Gut; 1987 Mar; 28(3):300-5. PubMed ID: 3552906
[TBL] [Abstract][Full Text] [Related]
5. [Encouragement for the tired stomach. Cisapride, a specific pro-kinetic drug for upset stomach].
Fortschr Med Suppl; 1990; 87():7-12. PubMed ID: 2351360
[No Abstract] [Full Text] [Related]
6. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying.
Bekhti A; Rutgeerts L
Postgrad Med J; 1979; 55 Suppl 1():30-2. PubMed ID: 382151
[TBL] [Abstract][Full Text] [Related]
7. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.
Jian R; Ducrot F; Ruskone A; Chaussade S; Rambaud JC; Modigliani R; Rain JD; Bernier JJ
Dig Dis Sci; 1989 May; 34(5):657-64. PubMed ID: 2653742
[TBL] [Abstract][Full Text] [Related]
9. A double-blind fluoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia.
Degryse H; De Schepper A; Verlinden M
Scand J Gastroenterol Suppl; 1993; 195():1-4. PubMed ID: 8516652
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials in nonulcer dyspepsia (NUD): a cautionary note. A closer look at "a double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia".
Champion MC
Can J Gastroenterol; 1997 Mar; 11(2):125-6. PubMed ID: 9113811
[No Abstract] [Full Text] [Related]
11. Dose-finding of cisapride in non-ulcer dyspepsia.
Verlinden M
Z Gastroenterol; 1990 Apr; 28 Suppl 1():31-5; discussion 72-3. PubMed ID: 2192504
[No Abstract] [Full Text] [Related]
12. Lack of efficacy of cisapride and nizatidine in dyspepsia.
Adelman A; Alper BS
J Fam Pract; 1998 Jun; 46(6):457-8. PubMed ID: 9638107
[No Abstract] [Full Text] [Related]
13. Efficacy of cisapride therapy in functional dyspepsia.
Kellow JE; Cowan H; Shuter B; Riley JW; Lunzer MR; Eckstein RP; Höschl R; Lam SK
Aliment Pharmacol Ther; 1995 Apr; 9(2):153-60. PubMed ID: 7605855
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients.
Tatsuta M; Iishi H; Nakaizumi A; Okuda S
Aliment Pharmacol Ther; 1992 Apr; 6(2):221-8. PubMed ID: 1600042
[TBL] [Abstract][Full Text] [Related]
15. Chronic oral treatment with cisapride decreases high bile salt reflux rates.
Müller-Lissner SA; Fraass C
Am J Gastroenterol; 1986 May; 81(5):354-7. PubMed ID: 3518407
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerability of cisapride in a new formula of 10 mg effervescent capsules for the treatment of functional dyspepsia].
Grossi L; Di Felice F; Marzio L
Clin Ter; 1993 Jun; 142(6):521-7. PubMed ID: 8354045
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of clebopride and placebo in dyspepsia secondary to delayed gastric emptying.
Bavestrello L; Caimi L; Barbera A
Clin Ther; 1985; 7(4):468-73. PubMed ID: 3893703
[TBL] [Abstract][Full Text] [Related]
18. [The typical patient with disorder of digestive motility].
Demling L
Fortschr Med Suppl; 1990; 87():17-9. PubMed ID: 2351357
[No Abstract] [Full Text] [Related]
19. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial.
Rösch W
Scand J Gastroenterol; 1987 Mar; 22(2):161-4. PubMed ID: 3554491
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cisapride in the treatment of epigastric pain and concomitant symptoms in non-ulcer dyspepsia.
Rösch W
Scand J Gastroenterol Suppl; 1989; 165():54-8. PubMed ID: 2690325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
